siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells

被引:24
|
作者
Furukawa, Kaori [1 ]
Tanaka, Masakazu [1 ]
Oba, Makoto [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan
关键词
Cell-penetrating peptide; siRNA delivery; Peptide foldamer; alpha; alpha-Disubstituted alpha-amino acid; Helical structure; ALPHA-AMINO-ACIDS; HELICAL PEPTIDES; NUCLEIC-ACIDS; AIB; DESIGN; VECTORS; RNA;
D O I
10.1016/j.bmc.2020.115402
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell-penetrating peptides (CPPs) are an attractive tool for delivering membrane-impermeable compounds, including anionic biomacromolecules such as DNA and RNA, into living cells. Amphipathic helical peptides composed of hydrophobic amino acids and cationic amino acids are typical CPPs. In the current study, we designed amphipathic helical 12-mer peptides containing alpha,alpha-disubstituted alpha-amino acids (dAAs), which are known to stabilize peptide secondary structures. The dominant secondary structures of peptides in aqueous solution differed according to the introduced dAAs. Peptides containing hydrophobic dAAs and adopting a helical structure exhibited a good cell-penetrating ability. As an application of amphipathic helical peptides, small interfering RNA (siRNA) delivery into living human hepatoma cells was investigated. One of the peptides containing dAAs dipropylglycine formed stable complexes with siRNA at appropriate zeta-potential and size for intracellular siRNA delivery. This peptide showed effective RNA interference efficiency at short peptide length and low concentrations of peptide and siRNA. These findings will be helpful for the design of amphipathic helical CPPs as intracellular siRNA delivery.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Development of Hydrophobic Cell-Penetrating Stapled Peptides as Drug Carriers
    Tsuchiya, Keisuke
    Horikoshi, Kanako
    Fujita, Minami
    Hirano, Motoharu
    Miyamoto, Maho
    Yokoo, Hidetomo
    Demizu, Yosuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [32] Targeted siRNA therapy using cytoplasm-responsive nanocarriers and cell-penetrating peptides
    Okada H.
    Journal of Pharmaceutical Investigation, 2014, 44 (7) : 505 - 516
  • [33] Cell-penetrating peptide TAT modified chitosan for siRNA delivery
    Yang, Feifei
    Li, Yunfei
    Huang, Wei
    Chen, Wei
    Jin, Mingji
    Gao, Zhonggao
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : E100 - E101
  • [34] Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery
    Yang, Jieru
    Luo, Yacheng
    Shibu, Mohini Anjna
    Toth, Istvan
    Skwarczynski, Mariusz
    CURRENT DRUG DELIVERY, 2019, 16 (05) : 430 - 443
  • [35] In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides
    Moulton, Hong M.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (16) : 2963 - 2969
  • [36] Cell-Penetrating Peptides Using Cyclic α,α-Disubstituted α-Amino Acids with Basic Functional Groups
    Kato, Takuma
    Oba, Makoto
    Nishida, Koyo
    Tanaka, Masakazu
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2018, 4 (04): : 1368 - 1376
  • [37] Cell-penetrating and cell-targeting peptides in drug delivery
    Vives, Eric
    Schmidt, Julien
    Pelegrin, Andre
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2008, 1786 (02): : 126 - 138
  • [38] Cell-Penetrating Peptides and Polymers for Improved Drug Delivery
    Gui Lin
    Zhang Xue-Hao
    Qiao Zeng-Ying
    Wang Hao
    CHEMNANOMAT, 2020, 6 (08): : 1138 - 1148
  • [39] Cell-penetrating peptides transport therapeutics into cells
    Ramsey, Joshua D.
    Flynn, Nicholas H.
    PHARMACOLOGY & THERAPEUTICS, 2015, 154 : 78 - 86
  • [40] Peptide-Ligand Binding Modeling of siRNA with Cell-Penetrating Peptides
    Garcia-Sosa, Alfonso T.
    Tulp, Indrek
    Langel, Kent
    Langel, Ulo
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014